BetterLife Selects CRO to Conduct Clinical Trials for AP-003 in COVID-19 Cases in Indonesia
January 21, 2021 08:30 ET
|
BetterLife Pharma
VANCOUVER, Jan. 21, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech focused on the development and...
BetterLife Confirms Non-controlled Status of 2-bromo-LSD with Health Canada
January 19, 2021 02:00 ET
|
BetterLife Pharma
VANCOUVER, Jan. 18, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and...
BetterLife Provides Shareholder Update and 2021 Product Development Roadmap
January 12, 2021 02:00 ET
|
BetterLife Pharma
VANCOUVER, Jan. 11, 2021 (GLOBE NEWSWIRE) -- VANCOUVER, January 12, 2021 - BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech focused...
BetterLife Announces Formation of Next Generation Psychedelic Research Advisory Board
January 07, 2021 09:00 ET
|
BetterLife Pharma
VANCOUVER, Jan. 07, 2021 (GLOBE NEWSWIRE) -- January 7, 2021 - BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company, is pleased...
BetterLife Files Patent for the Treatment of MDD Utilizing its Second-Generation Psychedelic Derivative for 2-Bromo-LSD
January 04, 2021 09:31 ET
|
BetterLife Pharma
VANCOUVER, Jan. 04, 2021 (GLOBE NEWSWIRE) -- January 4, 2021 - BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company, is pleased...
BetterLife Pharma Strengthens Board of Directors
December 29, 2020 02:00 ET
|
BetterLife Pharma
VANCOUVER, Dec. 28, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) CSE: BETR / OTCQB: BETRF / FRA: NPAU) an emerging biotech company, is pleased to announce that it...
BetterLife Welcomes Psychedelic Industry Leaders to the Senior Management Team
December 23, 2020 02:00 ET
|
BetterLife Pharma
VANCOUVER, Dec. 22, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) CSE: BETR / OTCQB: BETRF / FRA: NPAU) an emerging biotech company, is pleased to announce that...
BetterLife Closes Acquisition of Second Generation Psychedelic Assets of Transcend Biodynamics LLC
December 21, 2020 02:00 ET
|
BetterLife Pharma
VANCOUVER, Dec. 20, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU) is pleased to announce that further to its press release of...
BetterLife’s Recent Acquisition: Taking LSD from Experimental to a Major Therapeutic Application
December 15, 2020 02:00 ET
|
BetterLife Pharma
VANCOUVER, Dec. 14, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech focused on the development and...
BetterLife adds Next-Gen Psychedelic Therapy to its Pipeline of Drugs
December 08, 2020 08:56 ET
|
BetterLife Pharma
VANCOUVER, Dec. 08, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU) an emerging biotech focused on the development and...